SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-21-000060
Filing Date
2021-06-09
Accepted
2021-06-09 07:02:25
Documents
14
Period of Report
2021-06-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K siox-20210609.htm   iXBRL 8-K 42249
2 EX-99.1 siox8k_060921ex-991.htm EX-99.1 95219
6 GRAPHIC siox.jpg GRAPHIC 14099
  Complete submission text file 0001636050-21-000060.txt   314448

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20210609.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20210609_lab.xml EX-101.LAB 26189
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20210609_pre.xml EX-101.PRE 13698
7 EXTRACTED XBRL INSTANCE DOCUMENT siox-20210609_htm.xml XML 12217
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 211003962
SIC: 2834 Pharmaceutical Preparations